loader image
Monday, December 22, 2025
84.7 F
McAllen
- Advertisement -

Testicular Cancer: What Younger Men Should Know

Know the signs of cancer that strikes younger men

Translate to Spanish or other 102 languages!

For many men, prioritizing healthcare is not high on their to-do list, which can lead to many warning signs and symptoms flying under the radar. Here’s what to know when it comes to understanding and addressing this rare, but deadly, disease that primarily affects younger men. Image for illustration purposes
For many men, prioritizing healthcare is not high on their to-do list, which can lead to many warning signs and symptoms flying under the radar. Here’s what to know when it comes to understanding and addressing this rare, but deadly, disease that primarily affects younger men. Image for illustration purposes
- Advertisement -

SOUTH TEXAS HEALTH SYSTEM – We’re celebrating Men’s Health Month by spreading the word about testicular cancer. For many men, prioritizing healthcare is not high on their to-do list, which can lead to many warning signs and symptoms flying under the radar. Here’s what to know when it comes to understanding and addressing this rare, but deadly, disease that primarily affects younger men.

What is testicular cancer?

Testicular cancer starts in either one or both of the testicles, which are part of the male reproductive system. Cancer begins when cells start to grow out of control. These can form a tumor and sometimes spread to other areas of the body.

While less prevalent amongst men than prostate cancer, testicular cancer often develops without noticeable symptoms in its earliest stages. This means regular screenings and check-ups are vital for early detection. Performing self-examinations alongside routine visits with your physician can help identify potential issues ahead of time and offer more treatment options.

- Advertisement -

Who is most likely to get it?

Testicular cancer is not very common. The American Cancer Society estimates around 9,760 new cases of testicular cancer in 2024 and around 500 deaths. But the rates of this cancer have risen amongst men, especially those who are young or middle-aged, over several decades. Factors such as age, family history and an undescended testicle can affect one’s risk. The majority of cases occur in men between the ages of 15 and 35. Only about 8% occur in men ages 55 and older.

Symptoms may present themselves as:
A lump or swelling in the testicle
A feeling of heaviness
Dull aching or pain in the lower stomach or groin area
Enlargement or pain in breast tissue
Back pain

What should I do next?

If you notice any symptoms or have a family or personal history of testicular cancer, it’s always a good idea to speak to your doctor. Fostering an open conversation with your healthcare provider makes it more likely that you’ll receive the care and treatment you need and increase the chances of early detection.

Information source: South Texas Health Systems

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

6 Depression Symptoms in Midlife Linked to Almost 50% Higher Dementia Risk

In 2021, about 57 million people globally were living with dementia — an umbrella term for neurological conditions that impact a person’s cognitive skills and memory, such as Alzheimer’s disease and vascular dementia

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.
- Advertisement -
×